bioAffinity Technologies, Inc. Common Stock BIAF

$3.57 -2.46% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-10-15 View →
8-K 8-K 2026-10-13 View →
8-K 8-K 2026-10-09 View →
424B5 424B5 2026-10-09 View →
424B5 424B5 2026-10-09 View →
8-K 8-K 2026-10-08 View →
8-K 8-K 2026-10-06 View →
8-K 8-K 2026-09-30 View →
8-K 8-K 2026-09-22 View →
8-K 8-K 2026-09-17 View →
8-K 8-K 2026-09-11 View →
8-K 8-K 2026-09-09 View →
8-K 8-K 2026-09-03 View →
8-K 8-K 2026-09-01 View →
S-3 S-3 2026-08-27 View →
8-K 8-K 2026-08-20 View →
8-K 8-K 2026-08-18 View →
8-K 8-K 2026-08-14 View →
10-Q 10-Q 2026-08-07 View →
8-K 8-K 2026-08-07 View →
8-K 8-K 2026-07-31 View →
8-K 8-K 2026-07-27 View →
8-K 8-K 2026-07-22 View →
8-K 8-K 2026-07-07 View →
8-K 8-K 2026-06-30 View →
8-K 8-K 2026-06-18 View →
8-K 8-K 2026-06-16 View →
S-1 S-1 2026-06-12 View →
8-K 8-K 2026-06-02 View →
8-K 8-K 2026-05-27 View →
8-K 8-K 2026-05-12 View →
10-Q 10-Q 2026-05-11 View →
8-K 8-K 2026-05-08 View →
S-1 S-1 2026-04-30 View →
8-K 8-K 2026-04-30 View →
8-K 8-K 2026-04-14 View →
8-K 8-K 2026-04-07 View →
8-K 8-K 2026-04-01 View →
8-K 8-K 2026-03-26 View →
8-K 8-K 2026-03-25 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$3.57
Market Cap
$2.14 million
52-Week Range
$3.23 – $109.35
Average Volume
2.67 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.